Rentokil Initial (RKLIF) Net Income towards Common Stockholders (2022 - 2025)
Rentokil Initial (RKLIF) reported Net Income towards Common Stockholders of $156.0 million for Q3 2025, down 17.9% quarter-over-quarter from $190.0 million in Q4 2022.
Rentokil Initial (RKLIF) Net Income towards Common Stockholders (2022 - 2025) Analysis & Trends
Rentokil Initial (RKLIF) has 2 years of Net Income towards Common Stockholders data on file, last reported at $156.0 million in Q3 2025.
- Net Income towards Common Stockholders for Q3 2025 came in at $156.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $156.0 million (changed N/A YoY), and the FY2025 annual result was $470.0 million, up 19.28% from the prior year.
- Net Income towards Common Stockholders eased to $156.0 million in Q3 2025 per RKLIF's latest filing, from $190.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $190.0 million in Q4 2022 and troughed at $156.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 70.95 Bn | 70.77 Bn | 1.45 Bn | 502.50 Mn |
| 2 | Copart | 29.43 Bn | 26.09 Bn | 1.08 Bn | 401.39 Mn |
| 3 | Rb Global | 20.04 Bn | 19.85 Bn | 869.50 Mn | 124.60 Mn |
| 4 | UL Solutions | 19.54 Bn | 19.30 Bn | 381.00 Mn | 97.00 Mn |
| 5 | Global Payments | 18.52 Bn | 13.33 Bn | 1.70 Bn | -2.26 Bn |
| 6 | Aramark | 14.28 Bn | 13.87 Bn | 426.35 Mn | 102.14 Mn |
| 7 | Relx | 11.84 Bn | 11.60 Bn | - | - |
| 8 | Amentum Holdings | 5.58 Bn | 5.67 Bn | 345.00 Mn | 54.00 Mn |
| 9 | Dolby Laboratories | 5.00 Bn | 4.42 Bn | 350.90 Mn | 95.50 Mn |
| 10 | Rentokil Initial | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 156.00 Mn |
| Dec 31, 2022 | 190.01 Mn |